Literature DB >> 1279740

Ectopic pregnancy: evolution after treatment with transvaginal methotrexate.

M Atri1, P M Bret, T Tulandi, M K Senterman.   

Abstract

A prospective study was performed with 25 patients with ectopic pregnancies (EPs) who underwent treatment with transvaginal administration of methotrexate. Nineteen patients (76%) had positive responses to this treatment, and six (24%) had to undergo surgery: five because of increasing abdominal pain and one because of vaginal bleeding. The ultrasonographic (US) resolution of the EP was long and lagged behind the resolution at testing of levels of beta subunit of human chorionic gonadotropin (beta-hCG) in all patients. The fallopian tube in 12 (63%) of the responding group initially increased in diameter from a mean of 2.22 cm to a mean of 3.84 cm. In 13 (68%) of the responding group, it became more vascular at color Doppler examination. Eleven (92%) of the 12 EPs that increased in size also became more vascular. The increase in tubal size and vascularity, in spite of the falling beta-hCG level, represents a healing process and should cause no concern about the follow-up of these patients.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1279740     DOI: 10.1148/radiology.185.3.1279740

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  2 in total

1.  Methotrexate for the treatment of unruptured tubal pregnancy: a prospective nonrandomized study.

Authors:  Amélie Gervaise; Sylvie Capella-Allouc; François Audibert; Catherine Rongières-Bertrand; Yves Vincent; Hervè Fernandez
Journal:  JSLS       Date:  2003 Jul-Sep       Impact factor: 2.172

2.  The role of ultrasonography in methotrexate therapy for ectopic pregnancy.

Authors:  Piotr Czuczwar
Journal:  J Ultrason       Date:  2018
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.